Medical economics and the assessment of value in cardiovascular medicine: Part I

被引：78

作者：

Mark, DB

Hlatky, MA

机构：

[1] Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC 27715 USA

[2] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA

来源：

关键词：

cost-benefit analysis; cardiovascular diseases; financing;

D O I：

10.1161/01.CIR.0000021407.93752.7B

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：516 / 520

页数：5

共 9 条

[1] A CLINICIAN GUIDE TO COST-EFFECTIVENESS ANALYSIS [J].

DETSKY, AS ;

NAGLIE, IG .

[2]

Drummond M., 2015, METHODS EC EVALUATIO, V4

[3]

Gold MR, 1996, COST EFFECTIVENESS H

[4]

HLATKY MA, 2001, HEART DIS, P19

[5]

LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473

[6]

MARK DB, 2002, TXB CARDIOVASCULAR M, P957

[7] Introduction to health economics for physicians [J].

Meltzer, MI .

TORRANCE, GW .

Wright, JC ;

Weinstein, MC .